Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Intuitive Surgical Stock Performance
Shares of ISRG opened at $580.18 on Friday. The stock has a 50 day simple moving average of $549.32 and a 200 day simple moving average of $507.50. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The firm has a market capitalization of $206.65 billion, a PE ratio of 93.28, a P/E/G ratio of 5.19 and a beta of 1.39.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the stock. Berbice Capital Management LLC acquired a new position in Intuitive Surgical in the 4th quarter worth $26,000. Godsey & Gibb Inc. boosted its position in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the period. MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical during the third quarter worth about $33,000. Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical in the 4th quarter valued at approximately $36,000. Finally, Capital Performance Advisors LLP bought a new stake in Intuitive Surgical in the 3rd quarter valued at approximately $38,000. Institutional investors and hedge funds own 83.64% of the company’s stock.
Wall Street Analyst Weigh In
Check Out Our Latest Report on ISRG
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- Most Volatile Stocks, What Investors Need to Know
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- The How and Why of Investing in Gold Stocks
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Pros And Cons Of Monthly Dividend Stocks
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.